Reruns are fun.
This is my fav MASH re-run:
"I can't see CYP doing a FDA trial. To do so you basically have to follow in the footsteps of MSB. You can't do it remotely.
The resources and cash required does not fit into the CYP business model.
Mark all this down, little Lordy.
Saying you are doing something and actually doing it are two completely different things.
CYP doesn't have an office in the USA. There's step one. There's your progress for 2022 - Mark it down. And I don't reckon that will happen!"
What did they do in 2022? Nil progress.
And from 2021 to now? Progress, hey? Ok then.
The next couple of financials are gonna be interesting (if everything is on track as described by the Cynata team). Costs are incoming! Or are they?
I'll be here.
(20min delay)